Labuxtinib

• Description :

  Labuxtinib is c-kit tyrosine kinase inhibitor[1].

• CAS Number :

  [1426449-01-5]

• UNSPSC :

  12352005

• Target :

  C-Kit

• Type :

  Reference compound

• Related Pathways :

  Protein Tyrosine Kinase/RTK

• Applications :

  Cancer-Kinase/protease

• Field of Research :

  Cancer

• Assay Protocol :

  https://www.medchemexpress.com/labuxtinib.html

• Concentration :

  10mM

• Purity :

  99.76

• Solubility :

  DMSO : 125 mg/mL (ultrasonic)

• Smiles :

  CC1=CC=C(C2=NOC([C@@H]3[C@H](C3)F)=N2)C=C1NC(C4=CN=C5N4C=CC=C5)=O

• Molecular Formula :

  C20H16FN5O2

• Molecular Weight :

  377.37

• References & Citations :

  [1]Yeh Vince, et al. Imidazopyridine compounds and compositions as c-kit kinase inhibitors and their preparation. World Intellectual Property Organization, WO2013033070 A1. 2013-03-07.

• Shipping Conditions :

  Room Temperature

• Storage Conditions :

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported